Retatrutide entered 2026 with impressive Phase 2 data. Five positive Phase 3 studies have since changed the discussion.
The strongest obesity trial reported 70.3 pounds of average weight loss with 12 mg over 80 weeks. A two-year extension involving people who started with a BMI of at least 35...